GO:0044281 | small molecule metabolic process | 8.03% (11/137) | 3.14 | 0.0 | 2.2e-05 |
GO:0015930 | glutamate synthase activity | 2.19% (3/137) | 7.93 | 0.0 | 3e-05 |
GO:0046490 | isopentenyl diphosphate metabolic process | 1.46% (2/137) | 8.34 | 1.3e-05 | 0.000319 |
GO:0009240 | isopentenyl diphosphate biosynthetic process | 1.46% (2/137) | 8.34 | 1.3e-05 | 0.000319 |
GO:0050992 | dimethylallyl diphosphate biosynthetic process | 1.46% (2/137) | 8.34 | 1.3e-05 | 0.000319 |
GO:0016726 | oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor | 1.46% (2/137) | 8.34 | 1.3e-05 | 0.000319 |
GO:0050993 | dimethylallyl diphosphate metabolic process | 1.46% (2/137) | 8.34 | 1.3e-05 | 0.000319 |
GO:0051745 | 4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase activity | 1.46% (2/137) | 8.34 | 1.3e-05 | 0.000319 |
GO:0019288 | isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway | 1.46% (2/137) | 8.34 | 1.3e-05 | 0.000319 |
GO:1901566 | organonitrogen compound biosynthetic process | 6.57% (9/137) | 2.95 | 3e-06 | 0.000355 |
GO:1901576 | organic substance biosynthetic process | 8.03% (11/137) | 2.3 | 1.7e-05 | 0.000367 |
GO:0090407 | organophosphate biosynthetic process | 3.65% (5/137) | 4.02 | 1.6e-05 | 0.000376 |
GO:0043650 | dicarboxylic acid biosynthetic process | 1.46% (2/137) | 7.93 | 2.5e-05 | 0.000446 |
GO:0006536 | glutamate metabolic process | 1.46% (2/137) | 7.93 | 2.5e-05 | 0.000446 |
GO:0008703 | 5-amino-6-(5-phosphoribosylamino)uracil reductase activity | 1.46% (2/137) | 7.93 | 2.5e-05 | 0.000446 |
GO:0006537 | glutamate biosynthetic process | 1.46% (2/137) | 7.93 | 2.5e-05 | 0.000446 |
GO:0044249 | cellular biosynthetic process | 8.03% (11/137) | 2.4 | 9e-06 | 0.000448 |
GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors | 2.19% (3/137) | 6.26 | 8e-06 | 0.000476 |
GO:0009058 | biosynthetic process | 8.76% (12/137) | 2.29 | 7e-06 | 0.000531 |
GO:0019637 | organophosphate metabolic process | 4.38% (6/137) | 3.75 | 6e-06 | 0.000569 |
GO:0016491 | oxidoreductase activity | 10.22% (14/137) | 1.76 | 7.6e-05 | 0.001283 |
GO:0043648 | dicarboxylic acid metabolic process | 1.46% (2/137) | 6.93 | 0.000117 | 0.001724 |
GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | 1.46% (2/137) | 6.93 | 0.000117 | 0.001724 |
GO:1901135 | carbohydrate derivative metabolic process | 3.65% (5/137) | 3.44 | 0.000107 | 0.001726 |
GO:0019682 | glyceraldehyde-3-phosphate metabolic process | 1.46% (2/137) | 6.6 | 0.000187 | 0.002551 |
GO:0042726 | flavin-containing compound metabolic process | 1.46% (2/137) | 6.34 | 0.000273 | 0.002553 |
GO:0006081 | cellular aldehyde metabolic process | 1.46% (2/137) | 6.34 | 0.000273 | 0.002553 |
GO:0006771 | riboflavin metabolic process | 1.46% (2/137) | 6.34 | 0.000273 | 0.002553 |
GO:0009231 | riboflavin biosynthetic process | 1.46% (2/137) | 6.34 | 0.000273 | 0.002553 |
GO:0042727 | flavin-containing compound biosynthetic process | 1.46% (2/137) | 6.34 | 0.000273 | 0.002553 |
GO:0006082 | organic acid metabolic process | 4.38% (6/137) | 2.84 | 0.00021 | 0.002569 |
GO:0006090 | pyruvate metabolic process | 2.19% (3/137) | 4.78 | 0.000185 | 0.002623 |
GO:0043436 | oxoacid metabolic process | 4.38% (6/137) | 2.85 | 0.000207 | 0.002626 |
GO:0019752 | carboxylic acid metabolic process | 4.38% (6/137) | 2.85 | 0.000207 | 0.002626 |
GO:0009117 | nucleotide metabolic process | 2.92% (4/137) | 3.78 | 0.000223 | 0.002637 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 5.11% (7/137) | 2.52 | 0.000242 | 0.002775 |
GO:0006753 | nucleoside phosphate metabolic process | 2.92% (4/137) | 3.73 | 0.000254 | 0.002821 |
GO:0044283 | small molecule biosynthetic process | 3.65% (5/137) | 3.16 | 0.000268 | 0.002878 |
GO:0009064 | glutamine family amino acid metabolic process | 1.46% (2/137) | 6.12 | 0.000376 | 0.003335 |
GO:0009084 | glutamine family amino acid biosynthetic process | 1.46% (2/137) | 6.12 | 0.000376 | 0.003335 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.92% (4/137) | 3.53 | 0.000422 | 0.003652 |
GO:0018130 | heterocycle biosynthetic process | 3.65% (5/137) | 2.97 | 0.000478 | 0.003943 |
GO:0034641 | cellular nitrogen compound metabolic process | 6.57% (9/137) | 2.0 | 0.000475 | 0.004014 |
GO:0006766 | vitamin metabolic process | 1.46% (2/137) | 5.53 | 0.000859 | 0.006353 |
GO:0042364 | water-soluble vitamin biosynthetic process | 1.46% (2/137) | 5.53 | 0.000859 | 0.006353 |
GO:0006767 | water-soluble vitamin metabolic process | 1.46% (2/137) | 5.53 | 0.000859 | 0.006353 |
GO:0009110 | vitamin biosynthetic process | 1.46% (2/137) | 5.53 | 0.000859 | 0.006353 |
GO:0017144 | drug metabolic process | 2.92% (4/137) | 3.27 | 0.000841 | 0.006782 |
GO:1901293 | nucleoside phosphate biosynthetic process | 2.19% (3/137) | 3.81 | 0.00133 | 0.00926 |
GO:0009165 | nucleotide biosynthetic process | 2.19% (3/137) | 3.81 | 0.00133 | 0.00926 |
GO:0046483 | heterocycle metabolic process | 5.11% (7/137) | 2.1 | 0.001363 | 0.009305 |
GO:1901362 | organic cyclic compound biosynthetic process | 3.65% (5/137) | 2.65 | 0.0013 | 0.00942 |
GO:0008152 | metabolic process | 18.98% (26/137) | 0.89 | 0.001479 | 0.009906 |
GO:0009150 | purine ribonucleotide metabolic process | 2.19% (3/137) | 3.69 | 0.001688 | 0.010893 |
GO:0009259 | ribonucleotide metabolic process | 2.19% (3/137) | 3.69 | 0.001688 | 0.010893 |
GO:0006163 | purine nucleotide metabolic process | 2.19% (3/137) | 3.62 | 0.001956 | 0.0124 |
GO:0019693 | ribose phosphate metabolic process | 2.19% (3/137) | 3.6 | 0.002003 | 0.012476 |
GO:0008654 | phospholipid biosynthetic process | 1.46% (2/137) | 4.88 | 0.002125 | 0.012787 |
GO:0072521 | purine-containing compound metabolic process | 2.19% (3/137) | 3.58 | 0.0021 | 0.012851 |
GO:1901360 | organic cyclic compound metabolic process | 5.11% (7/137) | 1.97 | 0.002204 | 0.013043 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.19% (3/137) | 3.46 | 0.002682 | 0.015606 |
GO:0032787 | monocarboxylic acid metabolic process | 2.19% (3/137) | 3.42 | 0.002856 | 0.016352 |
GO:0006644 | phospholipid metabolic process | 1.46% (2/137) | 4.57 | 0.003265 | 0.018398 |
GO:0051536 | iron-sulfur cluster binding | 1.46% (2/137) | 4.47 | 0.003752 | 0.02049 |
GO:0051540 | metal cluster binding | 1.46% (2/137) | 4.47 | 0.003752 | 0.02049 |
GO:0008113 | peptide-methionine (S)-S-oxide reductase activity | 0.73% (1/137) | 7.93 | 0.004108 | 0.021766 |
GO:1901564 | organonitrogen compound metabolic process | 10.22% (14/137) | 1.16 | 0.004069 | 0.021888 |
GO:0051186 | cofactor metabolic process | 2.19% (3/137) | 3.17 | 0.00466 | 0.024328 |
GO:0006807 | nitrogen compound metabolic process | 10.95% (15/137) | 1.04 | 0.006308 | 0.031542 |
GO:0019363 | pyridine nucleotide biosynthetic process | 1.46% (2/137) | 4.09 | 0.00622 | 0.031544 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 1.46% (2/137) | 4.09 | 0.00622 | 0.031544 |
GO:0072525 | pyridine-containing compound biosynthetic process | 1.46% (2/137) | 4.07 | 0.006433 | 0.03172 |
GO:0046496 | nicotinamide nucleotide metabolic process | 1.46% (2/137) | 3.97 | 0.00732 | 0.035118 |
GO:0019362 | pyridine nucleotide metabolic process | 1.46% (2/137) | 3.97 | 0.00732 | 0.035118 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 1.46% (2/137) | 3.95 | 0.00755 | 0.035268 |
GO:0072524 | pyridine-containing compound metabolic process | 1.46% (2/137) | 3.95 | 0.00755 | 0.035268 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1.46% (2/137) | 3.8 | 0.009249 | 0.039561 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 1.46% (2/137) | 3.8 | 0.009249 | 0.039561 |
GO:0006754 | ATP biosynthetic process | 1.46% (2/137) | 3.8 | 0.009249 | 0.039561 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 1.46% (2/137) | 3.8 | 0.009249 | 0.039561 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 1.46% (2/137) | 3.8 | 0.009249 | 0.039561 |
GO:0055114 | oxidation-reduction process | 7.3% (10/137) | 1.28 | 0.008787 | 0.040513 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 1.46% (2/137) | 3.72 | 0.01029 | 0.040587 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.46% (2/137) | 3.72 | 0.01029 | 0.040587 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.46% (2/137) | 3.72 | 0.01029 | 0.040587 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.46% (2/137) | 3.72 | 0.01029 | 0.040587 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.46% (2/137) | 3.66 | 0.011102 | 0.040632 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.46% (2/137) | 3.66 | 0.011102 | 0.040632 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.46% (2/137) | 3.66 | 0.011102 | 0.040632 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.46% (2/137) | 3.66 | 0.011102 | 0.040632 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 2.19% (3/137) | 2.82 | 0.009012 | 0.041016 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 1.46% (2/137) | 3.68 | 0.010828 | 0.041334 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.46% (2/137) | 3.68 | 0.010828 | 0.041334 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 1.46% (2/137) | 3.68 | 0.010828 | 0.041334 |
GO:0046034 | ATP metabolic process | 1.46% (2/137) | 3.74 | 0.010025 | 0.041869 |
GO:1901607 | alpha-amino acid biosynthetic process | 1.46% (2/137) | 3.74 | 0.010025 | 0.041869 |
GO:0009260 | ribonucleotide biosynthetic process | 1.46% (2/137) | 3.57 | 0.012517 | 0.04192 |
GO:0046390 | ribose phosphate biosynthetic process | 1.46% (2/137) | 3.57 | 0.012517 | 0.04192 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.46% (2/137) | 3.57 | 0.012517 | 0.04192 |
GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives | 0.73% (1/137) | 6.6 | 0.010238 | 0.042263 |
GO:0006741 | NADP biosynthetic process | 0.73% (1/137) | 6.34 | 0.012274 | 0.042302 |
GO:0003951 | NAD+ kinase activity | 0.73% (1/137) | 6.34 | 0.012274 | 0.042302 |
GO:0016053 | organic acid biosynthetic process | 2.19% (3/137) | 2.68 | 0.011844 | 0.042471 |
GO:0046394 | carboxylic acid biosynthetic process | 2.19% (3/137) | 2.68 | 0.011844 | 0.042471 |
GO:0006520 | cellular amino acid metabolic process | 2.19% (3/137) | 2.67 | 0.011983 | 0.042541 |
GO:0009141 | nucleoside triphosphate metabolic process | 1.46% (2/137) | 3.59 | 0.012228 | 0.04298 |
GO:0006164 | purine nucleotide biosynthetic process | 1.46% (2/137) | 3.47 | 0.014313 | 0.045776 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 2.19% (3/137) | 2.59 | 0.013883 | 0.046061 |
GO:0015969 | guanosine tetraphosphate metabolic process | 0.73% (1/137) | 6.12 | 0.014305 | 0.046165 |
GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor | 0.73% (1/137) | 6.12 | 0.014305 | 0.046165 |
GO:0034035 | purine ribonucleoside bisphosphate metabolic process | 0.73% (1/137) | 6.12 | 0.014305 | 0.046165 |
GO:0072522 | purine-containing compound biosynthetic process | 1.46% (2/137) | 3.42 | 0.01525 | 0.048338 |
GO:0006139 | nucleobase-containing compound metabolic process | 3.65% (5/137) | 1.78 | 0.015693 | 0.0493 |
GO:0004096 | catalase activity | 0.73% (1/137) | 5.93 | 0.016331 | 0.04998 |